Amsterdam UMC researcher Dr. Przemek Krawczyk has developed FiglinQ: a cloud-based, collaborative platform for analysis, interactive plotting and publishing of research data in smart manuscripts. Earlier this year, Przemek was awarded an IXA Proof of Concept grant to launch FiglinQ, and since then several big milestones have been achieved: In June, the first smart manuscript generated with the use of FiglinQ was published in Nature. Later, FiglinQ received enthusiastic reactions from Elsevier and Springer-Nature. In December 2021, the spin-off company FiglinQ BV was incorporated. And shortly after the incorporation, an NWO Take Off Phase II loan of €250.000 was granted to FiglinQ BV to further develop and improve several key features of the platform, generate stable revenue streams and raise capital for further growth.
The UvA, VU, Amsterdam UMC, HvA and ROM InWest have just signed a collaboration agreement today on 12 March 2024. The parties are intensifying their collaboration for more entrepreneurship and innovation in Life Science Health (LSH). “Because of its knowledge institutions and the Netherlands’ largest academic hospital, Amsterdam is home to the top of Dutch […]
NewsThe Dutch chemical industry grapples with pressing challenges, such as green energy supply stability, the need for enhanced facilities and infrastructures to facilitate efficient scaling up of chemical processes, and the complexities surrounding material transition. These challenges underscore the imperative for increased innovation and robust public-private cooperation. Marco Tibaldi, from the Amsterdam Chemistry Network, explains […]
NewsIn the Life Sciences & Health round, 14 researchers have been selected for the Faculty of Impact programme for two years of intensive and personal guidance in entrepreneurship, intellectual property and investment. Four Amsterdam based researchers have been selected as well: Anouk Post (VU), Olivier Lugier (UvA), Felix Paulußen (VU) and Ewelina Weglarz-Tomczak (UvA). A […]
News